From Molecule to Market: Life Sciences AI Enters Governed Production
Black Book Research and Applied Artificial Intelligence LLC identify 2026-2027 client-rated technology leaders across 28 pharmaceutical, biotechnology and life sciences...
DNA
Providers Name 2027 Category Leaders in Sweeping Black Book Survey of Australia-New Zealand HIT Vendors
684 healthcare executives, clinicians and technology leaders rank vendors across 19 categories as buyers elevate interoperability, clinical continuity and implementation...
Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test
Submission includes a concurrent CLIA Waiver by Application for use of the test on the Co-Dx PCR Pro® instrument in...
Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test
Submission includes a concurrent CLIA Waiver by Application for use of the test on the Co-Dx PCR Pro® instrument in...
Haut.AI Launches AI-Powered Clinical Studies Software for Large-Scale Skin Studies Across Clinic, Hybrid, and At-Home Environments
Validated clinical studies software measures 48 biomarkers and reduces study setup time by more than 90%NEW YORK, Aug. 4, 2026...
Nabsys and Indiana University Collaborate to Advance Electronic Genome Mapping Applications in Hematologic Malignancies
Multi-year research collaboration will focus initially on AML and MDS while advancing Electronic Genome Mapping for broader hematologic research applicationsPROVIDENCE,...
Enlil Posts Strongest Quarter Yet, Fueled by New Customer Wins and Deeper Expansion Within Existing Customers
Five new customers in Q2 and 13 in the first half of 2026 — including expansion and multi-year agreements with...
Pharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near-term clinical readouts to support broader therapeutic use
For investor audiences and media only Second quarter 2026 total revenues decreased by 3% to US$90.2 million, compared to the...
BioNexus Advances VitaGuard™ Southeast Asia Rollout Following China Working Visit
Meetings in Shanghai and Changzhou link VitaGuard's commercial use in China with BioNexus' Southeast Asian plans and Fidelion's international licensing...
AGC Biologics Lands Commercial Manufacturing Agreement for Yokohama Site Worth Hundreds of Millions of Dollars
Upcoming AGC Biologics Manufacturing Facility in Yokohama, Japan This AGC Biologics site in Yokohama, Japan, as depicted in June 2026,...
Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland
New location expands access to advanced mental health treatments while serving as Greenbrook's flagship innovation center and blueprint for future...
NexTel Medical Corp. Advances Veterinary Oncology Strategy with Rollout of Early-Stage Cancer Screening for Companion Animals
Company targets a growing $1.2B+ North American pet oncology market leveraging proprietary exosome-based diagnostic technologies. ORLANDO, FL / ACCESS Newswire...
argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline
Transaction builds on argenx’s prior strategic investment in Forte Biosciences and reflects a disciplined approach to accessing novel biology that...
argenx Reports Half Year 2026 Financial Results and Provides Second Quarter Business Update
Strong second quarter performance with $1.5 billion in global product net sales, representing 60% year-over-year growth and 17% quarter-over-quarter growth...
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc
Group sales were +6% at constant exchange rates (CER)1, -2% when reported in CHF and +8% in USD2, in the...
OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th
BETHLEHEM, Pa., July 22, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it will report its...
Ottobock Releases One of the First-Ever Community-Built Image Libraries to Improve Representation of People with Limb Loss and Limb Differences in AI
The #DearAI , powered by Microsoft, built and annotated by people with limb loss and limb differences, is now publicly...
OraSure Receives Emergency Use Authorization for Second Generation Ebola Test
The rapid test detects the Bundibugyo virus associated with the current outbreak and can support the diagnosis of both symptomatic...
Tersis Technologies Appoints Vaughan B. Adnams as Chief Investment & Capital Markets Officer
Veteran Global Capital Markets Executive to Lead Institutional Finance, Strategic Investments and Global Project Funding as Tersis Accelerates International ExpansionBrooksville,...
Frishantic Launches Chelated Magnesium Glycinate for Nighttime Calm and Daily Muscle Ease
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Frishantic today announced the launch of Frishantic Magnesium Glycinate, a chelated magnesium...